These results are in line with available published transcriptomic data from in situ SCC tumors, in which SRC and RAPGEF1 expressions were slightly but significantly up-regulated compared to normal skin, and from in situ BCC tumors, in which SRC was also found significantly up-regulated71, 72 (data not shown). Here, RAPGEF1 is linked to skin basal cell carcinoma.